Warpaint London (LON:W7L – Get Free Report) released its earnings results on Wednesday. The company reported GBX 4.50 earnings per share for the quarter, Digital Look Earnings reports. Warpaint London had a net margin of 13.66% and a return on equity of 18.66%.
Warpaint London Stock Performance
Shares of LON W7L traded down GBX 26 during mid-day trading on Wednesday, hitting GBX 198. The company had a trading volume of 1,830,870 shares, compared to its average volume of 373,594. Warpaint London has a 12 month low of GBX 165 and a 12 month high of GBX 279.49. The firm has a market cap of £158.20 million, a P/E ratio of 11.17 and a beta of 0.43. The business’s 50-day simple moving average is GBX 208.28 and its 200-day simple moving average is GBX 203.24. The company has a debt-to-equity ratio of 12.22, a current ratio of 7.45 and a quick ratio of 1.56.
Wall Street Analyst Weigh In
W7L has been the subject of several recent analyst reports. Berenberg Bank restated a “buy” rating and set a GBX 425 target price on shares of Warpaint London in a research note on Wednesday. Shore Capital Group reiterated a “house stock” rating on shares of Warpaint London in a report on Tuesday, June 16th. Two analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, Warpaint London has an average rating of “Buy” and a consensus price target of GBX 432.50.
About Warpaint London
Warpaint London PLC, together with its subsidiaries, provides color cosmetics. It operates through two segments, Branded and Close-Out. The company offers its cosmetic skincare products under the W7, Technic, Man'stuff, Body Collection, Very Vegan, and Chit Chat brand names. It also provides supply chain management services. Warpaint London PLC sells its products to retailers, distributors, supermarkets, and retail chains, as well as through online. The company operates in the United Kingdom, rest of Europe, Spain, Denmark, the United States, Australia, New Zealand, and internationally.
Recommended Stories
- Five stocks we like better than Warpaint London
- Quantum and Rare Earths? Implications of the Pasqal/USAR Partnership
- Lockheed’s Stock Hasn’t Priced In Its Own Backlog—Boeing’s Might Already Have
- Eli Lilly Keeps Pulling Ahead—Can Novo Nordisk Catch Up?
- Old Dogs, New Tech: 3 Legacy Stocks Powering the AI Boom
Receive News & Ratings for Warpaint London Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Warpaint London and related companies with MarketBeat.com's FREE daily email newsletter.
